ANTHEM BIOSCIENCES
Back to Balance Sheet
|
ANTHEM BIOSCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹530 Cr | ₹485 Cr | ₹459 Cr | ₹279 Cr | ₹349 Cr |
What is the latest Total Current Liabilities ratio of ANTHEM BIOSCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹530 Cr |
| Mar2025 | ₹485 Cr |
| Mar2024 | ₹459 Cr |
| Mar2023 | ₹279 Cr |
| Mar2022 | ₹349 Cr |
How is Total Current Liabilities of ANTHEM BIOSCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹530 Cr | 9.17 | |
| Mar2025 | ₹485 Cr | 5.80 | |
| Mar2024 | ₹459 Cr | 64.46 | |
| Mar2023 | ₹279 Cr | -20.14 | |
| Mar2022 | ₹349 Cr | - | |
Compare Total Current Liabilities of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹44,142.4 Cr | 1.3% | 2.5% | 6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | 1.3% |
2.5% |
6.9% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses